CD105 (Endoglin) Mouse, anti-Human, RB780, Clone: 266, BD Horizon™

Mouse Monoclonal Antibody

Supplier:  BD Biosciences 568753

Catalog No. BDB568753

Description

The 266 monoclonal antibody specifically binds to CD105. CD105 is a type I transmembrane glycoprotein that is encoded by END (Endoglin) and belongs to the transforming growth factor-β (TGF-β) type III receptor family. CD105 is expressed on cells as a homodimer comprised of ∼95 kDa subunits. CD105 is expressed on vascular endothelial cells and placental syncytiotrophoblasts and at lower levels on stromal fibroblasts. It is also expressed on mesenchymal stem cells, erythroid precursors, activated macrophages, pre-B cells, and some tumor cells and cell lines including U937 cells. CD105 serves as a regulatory component of the TGF-β receptor system. In association with TGF- βRI or TGF- βRII, CD105 binds TGF-β1 and TGF-β3 with high affinity but does not bind to TGF-β2. Expression of CD105 is increased on activated endothelium in tissues undergoing angiogenesis, such as in tumors, or in cases of wound healing or dermal inflammation.

Specifications

• Antigen: CD105 (Endoglin)
• Clone: 266
• Formulation: Aqueous buffered solution containing ≤0.09% sodium azide
• Immunogen: Human Umbilical Vein Endothelial Cells
• Regulatory Status: RUO
• Gene ID (Entrez): 2022
• Content And Storage: Refrigerate (2°C to 8°C)

• Applications: Flow Cytometry
• Conjugate: RB780
• Host Species: Mouse
• Quantity: 25 Tests
• Primary or Secondary: Secondary
• Target Species: Human
• Isotype: IgG1 κ